Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Terns Pharmaceuticals Inc (NQ: TERN ) 7.645 -0.125 (-1.61%) Streaming Delayed Price Updated: 10:10 AM EDT, Aug 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 247,521 Open 7.500 Bid (Size) 7.630 (2) Ask (Size) 7.660 (6) Prev. Close 7.770 Today's Range 7.500 - 7.830 52wk Range 3.260 - 10.03 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) August 01, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire Terns Pharmaceuticals Appoints Biotech Executive Elona Kogan as Chief Legal Officer and Announces Upcoming CFO Transition July 29, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire Performance YTD +17.98% +17.98% 1 Month +13.76% +13.76% 3 Month +44.52% +44.52% 6 Month +45.34% +45.34% 1 Year +6.03% +6.03% More News Read More Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs? July 20, 2024 Via The Motley Fool TERN Stock Earnings: Terns Pharma Meets EPS for Q4 2023 March 14, 2024 Via InvestorPlace EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players' July 18, 2024 Via Benzinga Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session July 11, 2024 Via Benzinga Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday July 11, 2024 Via Benzinga Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation June 21, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) June 03, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences May 30, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day May 17, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire TERN Stock Earnings: Terns Pharma Beats EPS for Q1 2024 May 13, 2024 Via InvestorPlace Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates May 13, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire Terns Pharmaceuticals Announces Leadership Changes May 08, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024 May 07, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) May 03, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation April 29, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer April 10, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich March 25, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session March 21, 2024 Via Benzinga Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy? March 17, 2024 Via The Motley Fool Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates March 14, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia March 11, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) March 07, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences February 27, 2024 From Terns Pharmaceuticals, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
